Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Why Amgen Is Overvalued At $70 A Share
Why Amgen Is Overvalued At $70 A Share
Why Amgen Is Overvalued At $70 A Share
Submitted by
admin
on January 23, 2012 - 12:46pm
Source:
Seeking Alpha
News Tags:
Amgen
Headline:
Why Amgen Is Overvalued At $70 A Share
Do Not Allow Advertisers to Use My Personal information
